SPY391.84+4.34 1.12%
DIA319.49+4.10 1.30%
IXIC13,597.97+132.77 0.99%

BRIEF-EMA Says Reviewing Data On Monoclonal Antibody Use For Covid-19

· 02/04/2021 15:38
BRIEF-EMA Says Reviewing Data On Monoclonal Antibody Use For Covid-19

-

  • EMA REVIEWING DATA ON MONOCLONAL ANTIBODY USE FOR COVID-19

  • EMA - CHMP REVIEWING DATA ON USE OF MONOCLONAL ANTIBODIES CASIRIVIMAB, IMDEVIMAB, BAMLANIVIMAB & ETESEVIMAB TO TREAT COVID-19 PATIENTS

  • EMA - CHMP WILL CARRY OUT 2 SEPARATE REVIEWS, ONE FOR CASIRIVIMAB/IMDEVIMAB COMBINATION & ANOTHER FOR BAMLANIVIMAB/ETESEVIMAB

  • EMA - PRELIM RESULTS FOR BOTH STUDIES SHOW COMBINATIONS REDUCED VIRAL LOAD MORE THAN PLACEBO, LED TO FEWER COVID-19-RELATED MEDICAL VISITS, HOSPITALISATIONS

Source text: (https://bit.ly/3cGrUOx)


((Reuters.Briefs@thomsonreuters.com;))